Polatuzumab vedotina 140 mg Pó conc sol inj Fr IV

ID b73babad13d2fbd95751 · Portal da Transparência SNS
Price
Base Price
€19,410 .66
Effective Price
—
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33000000-0
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Company
Dates
Publication
08 Jul 2024
Celebration
15 Jul 2024
Contracting Entity
Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
NIF 506362299
Public body
Data Source
Portal da Transparência SNS
Api · synced 2026-02-27
Risk Flags
Score 35 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
19410.66
Threshold
20000.0
Rule
A5 threshold splitting: price within 5% below 20000.0
Detected 2026-03-06